捐赠者-接受者-捐赠者策略激发了一种双甲基的光动力疗法抗癌活性 (II) 复合体

Zhongyu Wang1,2, Li Wei2, Junfeng Lin2,3

  • 1School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R China.

PubMed
概括

这项研究通过开发一种新的双核 (Ru2) 复合物 (Ru2) 来增强癌症的光动力学治疗 (PDT). Ru2通过光敏化表现出优越的光吸收和强大的抗癌活性,为非侵入性癌症治疗提供了一个有前途的新策略.

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...